Recent research reported that KIF18B promotes hepatocellular carcinoma progression through activating the Wnt/β-catenin-signaling pathway [23], but the upstream regulators of KIF18B are unknown. This evidence concerns the gene KIF18B and hepatocellular carcinoma.